Natalia Sigal

Nov 1, 2024 | jitc.bmj.com | Natalia Sigal |Aiden Simpson |Marisa Miljkovic |Kristina Magee

http://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial.

Nov 1, 2024 | jitc.bmj.com | Kristina Magee |Natalia Sigal |Carlos Medina |Justin A. Jarrell

http://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial.

Jan 1, 2024 | jitc.bmj.com | Magdalena Kovacsovics-Bankowski |Johanna M. Sweere |Connor P. Healy |Natalia Sigal

Lower frequencies of circulating suppressive regulatory T cells and higher frequencies of CD4+ naïve T cells at baseline are associated with severe immune-related adverse events in immune checkpoint inhibitor-treated melanoma Statistics from Altmetric.com Request Permissions If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service.